{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:31:40Z","timestamp":1778549500907,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1002\/jps.21476","type":"journal-article","created":{"date-parts":[[2008,7,11]],"date-time":"2008-07-11T20:27:06Z","timestamp":1215808026000},"page":"926-944","source":"Crossref","is-referenced-by-count":36,"title":["Effects of Chemical Enhancers on Human Epidermal Membrane: Structure-Enhancement Relationship Based on Maximum Enhancement (Emax)"],"prefix":"10.1016","volume":"98","author":[{"given":"Sarah A.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.Kevin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21476_bb0010","series-title":"Percutaneous penetration enhancers","author":"Smith","year":"2006"},{"key":"10.1002\/jps.21476_bb0015","series-title":"Enhancement in Drug Delivery","author":"Touitou","year":"2006"},{"key":"10.1002\/jps.21476_bb0020","series-title":"Pharmaceutical Skin Penetration Enhancement","author":"Walters","year":"1993"},{"key":"10.1002\/jps.21476_bb0025","series-title":"Skin delivery systems: Transdermals, dermatologicals, and cosmetic actives","author":"Wille","year":"2006"},{"key":"10.1002\/jps.21476_bb0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0378-5173(00)00330-6","article-title":"The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems","volume":"198","author":"El-Kattan","year":"2000","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0378-5173(91)90269-T","article-title":"Influence of oleic-acid and other permeation promoters on transdermal delivery of dihydroergotamine through rabbit skin","volume":"67","author":"Niazy","year":"1991","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-5173(93)90388-V","article-title":"Effect of penetration enhancers (pyrrolidone derivatives) on multilamellar liposomes of stratum-corneum lipid\u2014A study by UV spectroscopy and differential scanning calorimetry","volume":"95","author":"Kim","year":"1993","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0378-5173(93)90054-J","article-title":"Azone(R) and the formation of reversed monocontinuous and bicontinuous lipid-water phases","volume":"98","author":"Engblom","year":"1993","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0050","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.2042-7158.1997.tb06023.x","article-title":"Effects of penetration enhancers on the in-vitro percutaneous absorption of progesterone","volume":"49","author":"Valenta","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21476_bb0055","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1248\/bpb.27.1819","article-title":"Essential oils from sweet basil (Ocimum basilicum) as novel enhancers to accelerate transdermal drug delivery","volume":"27","author":"Fang","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.21476_bb0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/js950471x","article-title":"Fluorescent probe studies of the interactions of 1-alkyl-2-pyrrolidones with stratum corneum lipid liposomes","volume":"85","author":"Yoneto","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0065","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1248\/bpb.18.1566","article-title":"Percutaneous penetration of fluorescein isothiocyanate-dextrans and the mechanism for enhancement effect of enhancers on the intercellular penetration","volume":"18","author":"Ogiso","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.21476_bb0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0005-2736(93)90418-Y","article-title":"Enhanced permeation and stratum-corneum structural alterations in the presence of dithiothreitol","volume":"1153","author":"Goates","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jps.21476_bb0075","series-title":"Solvent Systems and Their Selection in Pharmaceutics and Biopharmaceutics","author":"Augustijns","year":"2007"},{"key":"10.1002\/jps.21476_bb0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000107575","article-title":"Percutaneous penetration enhancers: An overview","volume":"20","author":"Thong","year":"2007","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1002\/jps.21476_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2006.07.001","article-title":"Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery","volume":"115","author":"Karande","year":"2006","journal-title":"J Control Release"},{"key":"10.1002\/jps.21476_bb0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-3659(98)00187-4","article-title":"Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations","volume":"59","author":"Suhonen","year":"1999","journal-title":"J Control Release"},{"key":"10.1002\/jps.21476_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2004.06.010","article-title":"The effect of penetration enhancers on drug delivery through skin: A QSAR study","volume":"99","author":"Ghafourian","year":"2004","journal-title":"J Control Release"},{"key":"10.1002\/jps.21476_bb0100","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1073\/pnas.0501176102","article-title":"Design principles of chemical penetration enhancers for transdermal drug delivery","volume":"102","author":"Karande","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jps.21476_bb0105","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1211\/jpp.57.11.0003","article-title":"Discriminant analysis as a tool to identify compounds with potential as transdermal enhancers","volume":"57","author":"Pugh","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21476_bb0110","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jps.20030","article-title":"Mechanistic study of chemical skin permeation enhancers with different polar and lipophilic functional groups","volume":"93","author":"He","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0115","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/jps.10550","article-title":"Mechanistic studies of branched-chain alkanols as skin permeation enhancers","volume":"93","author":"Chantasart","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/jps.1068","article-title":"Influences of alkyl group chain length and polar head group on chemical skin permeation enhancement","volume":"90","author":"Warner","year":"2001","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0125","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/jps.10367","article-title":"Structure-activity relationship for chemical skin permeation enhancers: Probing the chemical microenvironment of the site of action","volume":"92","author":"Warner","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0130","series-title":"Percutaneous Penetration Enhancers","first-page":"35","article-title":"Quantitative structure-enhancement relationship and the microenvironment of the enhancer site of action","author":"Li","year":"2006"},{"key":"10.1002\/jps.21476_bb0135","series-title":"Percutaneous Penetration Enhancers","first-page":"271","article-title":"Mechanistic studies of permeation enhancers","author":"Li","year":"2006"},{"key":"10.1002\/jps.21476_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00625-7","article-title":"Mechanistic studies of the effect of hydroxypropyl-beta-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin","volume":"253","author":"Shaker","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0145","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jps.21094","article-title":"Silicone elastomer uptake method for determination of free 1-alkyl-2-pyrrolidone concentration in micelle and hydroxypropyl-beta-cyclodextrin systems used in skin transport studies","volume":"97","author":"Warner","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0150","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1021\/js980026c","article-title":"Enhanced transdermal delivery of sex hormones in swine with a novel topical aerosol","volume":"87","author":"Morgan","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0155","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/js980025k","article-title":"Enhanced skin permeation of sex hormones with novel topical spray vehicles","volume":"87","author":"Morgan","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0160","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jps.2600840813","article-title":"The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membrane","volume":"84","author":"Peck","year":"1995","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0165","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jps.20122","article-title":"A novel method for determination of drug solubility in polymeric matrices","volume":"93","author":"Jasti","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(93)90050-P","article-title":"Improved stability of the human epidermal membrane during successive permeability experiments","volume":"98","author":"Peck","year":"1993","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0175","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/jps.20865","article-title":"Comparison of the effects of chemical permeation enhancers on the lipoidal pathways of human epidermal membrane and hairless mouse skin and the mechanism of enhancer action","volume":"96","author":"Chantasart","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-4347(98)00571-4","article-title":"Quantitative analysis of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol in human plasma using high-performance liquid chromatography","volume":"724","author":"Taras","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1002\/jps.21476_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2005.01.041","article-title":"Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers","volume":"297","author":"He","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0190","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/1523-1747.ep12338682","article-title":"Water increases the fluidity of intercellular membranes of stratum corneum: Correlation with water permeability, elastic, and electrical resistance properties","volume":"106","author":"Alonso","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1002\/jps.21476_bb0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejps.2006.11.014","article-title":"The influence of drug partition coefficient on follicular penetration: In vitro human skin studies","volume":"30","author":"Frum","year":"2007","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.21476_bb0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(01)00808-0","article-title":"Effect of melting point of chiral terpenes on human stratum corneum uptake","volume":"228","author":"Mackay","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.optcom.2007.06.055","article-title":"Evaluation of skin optical clearing enhancement with Azone as a penetration enhancer","volume":"279","author":"Xu","year":"2007","journal-title":"Optics Commun"},{"key":"10.1002\/jps.21476_bb0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2006.05.049","article-title":"Combination strategies for enhancing transdermal absorption of sumatriptan through skin","volume":"323","author":"Femenia-Fonta","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0215","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cis.2006.05.014","article-title":"Microemulsions as transdermal drug delivery vehicles","volume":"123","author":"Kogan","year":"2006","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1002\/jps.21476_bb0220","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/03639040500529168","article-title":"Bicontinuous water-AOT\/Tween85-isopropyl myristate microemulsion: A new vehicle for transdermal delivery of cyclosporin A","volume":"32","author":"Liu","year":"2006","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.21476_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0939-6411(01)00158-8","article-title":"Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin","volume":"52","author":"Larrucea","year":"2001","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.21476_bb0230","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2174\/0929867003374840","article-title":"Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery","volume":"7","author":"Kanikkannan","year":"2000","journal-title":"Curr Med Chem"},{"key":"10.1002\/jps.21476_bb0235","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1023\/A:1015921702258","article-title":"Structure effect studies of fatty-acid isomers as skin penetration enhancers and skin irritants","volume":"6","author":"Aungst","year":"1989","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21476_bb0240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1023\/A:1012099216060","article-title":"In vitro human skin barrier modulation by fatty acids: Skin permeation and thermal analysis studies","volume":"14","author":"Tanojo","year":"1997","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21476_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0378-5173(96)04609-1","article-title":"Mechanisms of action of skin penetration enhancers retarders: Azone and analogues","volume":"141","author":"Hadgraft","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0250","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1248\/cpb.36.3702","article-title":"Duration and reversibility of the penetration-enhancing effect of azone","volume":"36","author":"Adachi","year":"1988","journal-title":"Chem Pharm Bull"},{"key":"10.1002\/jps.21476_bb0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-5173(86)90095-5","article-title":"Penetration enhancing effect of azone on the transport of 5-fluorouracil across the hairless rat skin","volume":"32","author":"Morimoto","year":"1986","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0260","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0378-5173(95)04319-5","article-title":"Differences in penetration-enhancing effect of Azone through excised rabbit, rat, hairless mouse, guinea pig and human skins","volume":"130","author":"Niazy","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0265","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.fct.2007.06.021","article-title":"Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients","volume":"45","author":"Kroes","year":"2007","journal-title":"Food Chem Toxicol"},{"key":"10.1002\/jps.21476_bb0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0300-483X(02)00194-4","article-title":"Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity","volume":"177","author":"Fujisawa","year":"2002","journal-title":"Toxicology"},{"key":"10.1002\/jps.21476_bb0275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/B:MODI.0000047498.49219.ab","article-title":"QSPR modeling the aqueous solubility of alcohols by optimization of correlation weights of local graph invariants","volume":"8","author":"Duchowicz","year":"2004","journal-title":"Mol Divers"},{"key":"10.1002\/jps.21476_bb0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0378-5173(88)90095-6","article-title":"Enhancing effect of pyrrolidone derivatives on transdermal drug delivery. 1","volume":"44","author":"Sasaki","year":"1988","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21476_bb0285","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mrgentox.2006.11.012","article-title":"Proposed criteria for specific and non-specific chromosomal genotoxicity based on hydrophobic interactions","volume":"628","author":"Dorn","year":"2007","journal-title":"Mutat Res Genet Toxicol Environ Mutagenesis"},{"key":"10.1002\/jps.21476_bb0290","first-page":"87","article-title":"Transdermal drug delivery: Efficacy and potential applications of the penetration enhancer Azone","volume":"6","author":"Wiechers","year":"1990","journal-title":"Drug Des Deliv"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916373324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916373324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T16:40:47Z","timestamp":1557679247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916373324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0022354916373324"],"URL":"https:\/\/doi.org\/10.1002\/jps.21476","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}